PEOPLE - Osiris Therapeutics (US) forms new senior management team:
This article was originally published in Clinica
Executive Summary
US company Osiris Therapeutics has formed a senior management team which will focus on the commercialisation of its adult stem cell products. It includes Dr Annemarie Moseley as senior vice-president of clinical and regulatory affairs; Dr Daniel Marshak, senior vice-president and chief scientific officer; John Coker, vice-president and chief financial officer, secretary and treasurer; Dr Stewart Craig, vice-president of development and operations; Dr Robert Deans, vice-president of applied research; Dr Stephen Gordon, vice-president of advanced technology management; and Kenneth Moseley, vice-president of patents and business development.